- Home
- CROX vs BRKR Comparison
CROX vs BRKR Comparison
Compare CROX & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CROX | BRKR |
|---|---|---|
| Founded | 1999 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Shoe Manufacturing | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.2B | 6.7B |
| IPO Year | 2005 | 2000 |
Fundamental Metrics
Financial Performance| Metric | CROX | BRKR |
|---|---|---|
| Price | $132.86 | $60.07 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 13 |
| Target Price | ★ $99.90 | $48.54 |
| AVG Volume (30 Days) | 1.0M | ★ 2.2M |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 0.58% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 2.71 | 0.02 |
| Revenue | ★ $4,040,647,000.00 | $1,895,600,000.00 |
| Revenue This Year | $2.01 | $6.30 |
| Revenue Next Year | $2.60 | $3.81 |
| P/E Ratio | ★ $46.91 | $3,030.00 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $73.21 | $28.53 |
| 52 Week High | $129.79 | $64.54 |
Technical Indicators
Market Signals| Indicator | CROX | BRKR |
|---|---|---|
| Relative Strength Index (RSI) | 64.08 | 59.08 |
| Support Level | $82.49 | $34.20 |
| Resistance Level | N/A | $63.79 |
| Average True Range (ATR) | 4.78 | 2.49 |
| MACD | -0.08 | -0.40 |
| Stochastic Oscillator | 91.73 | 68.08 |
Price Performance
Historical ComparisonAbout CROX Crocs Inc.
Crocs Inc is engaged in the design, development, marketing, distribution, and sale of casual lifestyle footwear accessories for men, women, and children. The reportable operating segments of the company are the Crocs Brand and the HEYDUDE Brand. The company derives maximum revenue from the Crocs brand segment.
About BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.